methylprednisolone has been researched along with praziquantel in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (43.75) | 29.6817 |
| 2010's | 7 (43.75) | 24.3611 |
| 2020's | 2 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Alexander, P; Idris, M; Joseph, K; Koul, R; Scrimgeour, E | 1 |
| Cunha, AS; Ferrari, TC; Moreira, PR | 1 |
| Choi, MH; Chung, BS; Hong, ST; Jeon, D; Lee, M; Li, S; Zhang, H | 1 |
| Jeong, SM; Kim, JS; Moon, SY; Park, SH | 1 |
| Antunes, CM; Lambertucci, JR; Maciel, PE; Ribas, JG; Silva, LC; Souza-Pereira, SR | 1 |
| Botterel, F; Brugières, P; Hosseini, H; Liance, M; Perignon, A; Poirier, P | 1 |
| Chen, J; Chen, LY; Xia, Y | 1 |
| Dhir, A; Jillella, DV; Landzberg, DR | 1 |
| Chew, R | 1 |
1 review(s) available for methylprednisolone and praziquantel
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
15 other study(ies) available for methylprednisolone and praziquantel
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Schistosoma mansoni myeloradiculopathy in an 8-year-old Omani boy.
Topics: Animals; Anthelmintics; Child; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Neuroschistosomiasis; Oman; Parasite Egg Count; Praziquantel; Schistosoma mansoni; Schistosomiasis mansoni; Time Factors; Treatment Outcome | 2002 |
Spinal cord schistosomiasis: a prospective study of 63 cases emphasizing clinical and therapeutic aspects.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Antiplatyhelmintic Agents; Biopsy; Child; Child, Preschool; Disease Progression; Female; Humans; Immunoglobulin G; Low Back Pain; Male; Methylprednisolone; Middle Aged; Muscle, Skeletal; Nervous System Diseases; Neurologic Examination; Neuroschistosomiasis; Pain; Pain Measurement; Patient Selection; Praziquantel; Prednisone; Prospective Studies; Radiculopathy; Reflex, Stretch; Spinal Cord; Tomography, X-Ray Computed; Treatment Outcome | 2004 |
Development of resistance to reinfection by Clonorchis sinensis in rats.
Topics: Animals; Anthelmintics; Anti-Inflammatory Agents; Clonorchiasis; Clonorchis sinensis; Cricetinae; Disease Models, Animal; Female; Immunocompetence; Immunosuppression Therapy; Male; Mesocricetus; Methylprednisolone; Praziquantel; Rats; Rats, Sprague-Dawley | 2004 |
Third cranial nerve palsy from midbrain neurocysticercosis: repeated exacerbation on tapering corticosteroids.
Topics: Animals; Antibodies, Protozoan; Antiprotozoal Agents; Blepharoptosis; Cerebrospinal Fluid; Cysticercus; Diplopia; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Glucocorticoids; Humans; Magnetic Resonance Imaging; Male; Mesencephalon; Methylprednisolone; Middle Aged; Neurocysticercosis; Oculomotor Nerve Diseases; Praziquantel; Recurrence | 2004 |
Treatment of schistosomal myeloradiculopathy with praziquantel and corticosteroids and evaluation by magnetic resonance imaging: a longitudinal study.
Topics: Adolescent; Adult; Anthelmintics; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Neuroschistosomiasis; Praziquantel; Prospective Studies; Radiculopathy | 2004 |
[Sciatica after return from Mali: case report of schistosomal myelopathy].
Topics: Adult; Anthelmintics; Diagnosis, Differential; Glucocorticoids; Humans; Male; Mali; Methylprednisolone; Neuroschistosomiasis; Praziquantel; Schistosomiasis mansoni; Sciatica | 2009 |
Intraorbital paragonimus infection.
Topics: Animals; Anthelmintics; Antibodies, Helminth; Child, Preschool; Diagnosis, Differential; Drug Therapy, Combination; Eye Infections, Parasitic; Female; Glucocorticoids; Humans; Magnetic Resonance Imaging; Methylprednisolone; Ophthalmologic Surgical Procedures; Orbital Diseases; Paragonimiasis; Paragonimus; Praziquantel | 2019 |
Radiographic Improvement of Larval Cysts in Neurocysticercosis.
Topics: Adult; Albendazole; Anthelmintics; Anticonvulsants; Brain; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Neurocysticercosis; Neuroprotective Agents; Praziquantel; Seizures; Treatment Outcome | 2021 |
Probable Spinal Neuroschistosomiasis Manifesting as Transverse Myelitis.
Topics: Adult; Anthelmintics; Fecal Incontinence; Glucocorticoids; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Myelitis, Transverse; Neuralgia; Neuroschistosomiasis; Paraplegia; Praziquantel; Prednisolone; Pulse Therapy, Drug; Urinary Incontinence | 2021 |